Data from public SEC 13F & STOCK Act filings, delayed up to ~45 days, partial holdings only — for research, not investment advice.
CRSP
CRISPR THERAPEUTICS AGData as of 2026 Q1 (03-31) · 13F snapshot
Summary
CRISPR THERAPEUTICS AG (CRSP) is held by 6 tracked hedge-fund managers, a combined reported value of ~$625.24M; the largest are Cathie Wood, Ken Griffin, Ken Griffin. This quarter: 3 added. 4 members of Congress have disclosed STOCK Act trades. Data as of 2026 Q1, from public SEC 13F filings, delayed up to ~45 days.
Attention · MediumThis quarter · Heating up
Gurus holding6
Congress trades4
Price$49.80vs quarter-end+4.69%
Sectors3
This quarter's moves
Top holderCathie WoodNew0
Added3
Trimmed / sold0
Value $27.22M— of portfolio572,3002026 Q1
Value $12.32M— of portfolio258,9002026 Q1
Value $1.55M— of portfolio33,0002024 Q3
Value $1.25M— of portfolio26,3002026 Q1
Value $837.2K— of portfolio17,6002026 Q1
Value $389.0K— of portfolio2,4002021 Q2
Value $85.0K— of portfolio1,3002022 Q3
| Investor | Value | % of portfolio | Action |
|---|---|---|---|
| Ken GriffinPUT | $27.22M | — | — |
| Ken GriffinCALL | $12.32M | — | — |
| Izzy EnglanderCALL | $1.55M | — | — |
| Steven CohenCALL | $1.25M | — | — |
| Steven CohenPUT | $837.2K | — | — |
| Izzy EnglanderPUT | $389.0K | — | — |
| Cathie WoodCALL | $85.0K | — | — |